Skip to main content

BioMarin CEO says 'the system will have to determine' the worth of its new $702,000 drug

Jim Cramer spoke with JJ Bienaimé for more on the company's newest drug that treats a very rare disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.